Proposals for Next Classification Schema of Myeloid Neoplasms
Blood Cancers Today: Therapy-Related CHIP
All-Oral Regimen for Newly Diagnosed AML
Health Informatics And Implementation Science
Biostatistics And Health Services Research
Elisabeth Chair for the Dean of Medicine
Donna M. and Robert J. Manning Chair in Obstetrics and Gynecology
Daniel Mullin, PsyD, MPH Director, Center for Integrated Primary Care Professor, Department of Family Medicine and Community Health UMass Chan Medical School
Joy McCann Professor for Women in Medicine
Additional information about lab rotations within the CPHR program can be found athttp://www.umassmed.edu/cphr/program/rotations.aspx
Imoigele P. Aisiku, MD’97 Chair in Health Equity and Diversity
Barbara Helen Smith Chair in Preventive & Behavioral Medicine
Susan Lynn Sullivan-Bolyai DNSc, MN, RN, CNS, FAAN
Richard M. Haidack Professor in Medicine
Dr. John Meyers Professor in Primary Care Medicine
Population and Quantitative Health Sciences
UMass Worcester Prevention Research Center
Prevention Research Center at UMass Chan
Tweets by @DrSherryPagoto
Emergency Medicine at UMass Chan - Baystate
Healthcare Delivery and Population Sciences at UMass Chan - Baystate
Susan D Moffatt-Bruce MD, PhD, FRCSC, MBOE, MBA,FACS
Priscilla K. Gazarian PhD, CNS, RN, FAAN
Priscilla Gazarian, PhD CNS RN, is Professor of Nursing and Associate Dean for Academic Affairs in the Tan Chingfen Graduate School of Nursing.
Joseph D. Early Chair in Biomedical Research
Prevention Strategies for Second Primary Malignancies After CAR-T Therapy
The Darkest Side of AML: The TP53 Mutation
Clonal Hematopoiesis in Clinical Practice: Real-World Insights
Unpacking CHIP: Recent Updates, Remaining Questions
Dr Patel on the Impact of Donor-Engrafted Clonal Hematopoiesis on Outcomes With Auto-/Allo-HSCT
Effects of donor-engrafted clonal hematopoiesis in stem cell transplantation
High-Risk Myelodysplastic Syndrome Findings in the SELECT-MDS-1 Study
Stem Cell Transplantation: How Clonal Hematopoiesis Shapes Patient Outcomes
Olutasidenib as a Breakthrough for R/R mIDH1 AML Patients
The Impact of Mutations in Clonal Hematopoiesis
TP53 in MDS & AML Prognostication & Treatment Strategies
Exploring the Biological Basis of TP53-Aberrant MDS & AML
Improving Outcomes in Blast Phase Chronic Myeloid Leukemia
ASH Clinical News - Practical Solutions Amid Cuts to Federally Funded Research
OncLive with Dr. Patel and Dr. Gerber: p53 Immunohistochemistry
Early Identification of TP53-Mutant MDS and AML Using p53 Immunostaining
Point-of-Care p53 IHC Unveils TP53-Mutant MDS/AML
IHC Enables Rapid Identification of TP53-Mutant MDS/AML
ASH Clinical News: p53 Immunohistochemistry for TP53-Mutant MDS/AML
p53 Immunostain in TP53-Mutant MDS and AML